Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma [11]

R. Fenk, B. Hoyer, U. Steidl, M. Kondakci, T. Graef, R. Heuk, L. Ruf, C. Strupp, F. Neumann, U. P. Rohr, B. Hildebrandt, R. Haas, G. Kobbe

Research output: Contribution to journalLetter

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)156-159
Number of pages4
JournalLeukemia
Volume19
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Fenk, R., Hoyer, B., Steidl, U., Kondakci, M., Graef, T., Heuk, R., Ruf, L., Strupp, C., Neumann, F., Rohr, U. P., Hildebrandt, B., Haas, R., & Kobbe, G. (2005). Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma [11]. Leukemia, 19(1), 156-159. https://doi.org/10.1038/sj.leu.2403564